Marinus Pharmaceuticals Inc
(STU:61Y)
€
0.292
0.076 (35.19%)
Market Cap: 19.67 Mil
Enterprise Value: 32.91 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 36/100 Marinus Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 15, 2020 / 05:15PM GMT
Release Date Price:
€11.36
(+57.78%)
Rahul D Sood;Morgan Stanley;Senior Consultant
Scott and Ed, welcome to the Morgan Stanley Conference. Good to see you guys here and appreciate your time.
Scott Braunstein
Marinus Pharmaceuticals, Inc. - CEO & President
Thanks, Rahul. Appreciate you taking the time to lead this session.
Rahul D Sood;Morgan Stanley;Senior Consultant
No, of course, and a little bit of a strange time these days, given this is all virtual. But before we begin, I would point everyone who is attending today's session to go to Morgan Stanley -- to review Morgan Stanley's research disclosure by going to our website and taking a look at it.
Questions & Answers
Rahul D Sood;Morgan Stanley;Senior Consultant
So with that, Scott, you guys are on a -- you guys are on a bit of a roll here with the Marigold Study announcement for the CDKL5 that -- the data that was released yesterday. Why don't we just start
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot